Tagged With "inhalers"

Blog Post

Teva Announces FDA Approval of QVAR® RediHaler™ Inhaler

AAFA Community Services ·
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved QVAR® RediHaler™ (beclomethasone dipropionate HFA) inhalation aerosol, a breath-actuated inhaler for the maintenance treatment of asthma as a prophylactic therapy in patients 4 years of age and older.
×
×
×
×